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Lujan syndrome (OMIM #309520; AKA Lujan-Fryns syndrome, X-linked Intellectual Disability-
Marfanoid habitus) is an X-linked disorder with intellectual disability, general asthenia, and long 
narrow face with high palate, small mandible and hyper nasal voice [1-3]. Although the affected 
males in the original family reported by Lujan had is sense mutation in MED12, only minorities 
of other males with this phenotype have been found to harbor mutations in this gene. This report 
describes 3 brothers with the Lujan syndrome phenotype who have a pathogenic mutation in 
SLC6A8 and biochemical findings typical of creatine transporter defect (OMIM 300352) [4]. The 
family was studied under the protocol reviewed and approved by the Self Regional Healthcare 
Institutional Review Board (SRHIRB). The mother provided informed consent for participation 
in the research and for publication of the photographs. The oldest brother (II-1) in kindred K9377 
had normal prenatal growth (birth weight 3.8 kg), walked at 18 months, had delayed speech, and 
developed seizures prior to age 5 years. At age 24 years, he had height of 188 cm (97th centile), span of 
190 cm (80th centile), weight of 80 kg (60th centile) and head circumference of 59.5 cm (95th centile). 
The face was expressionless with prominent forehead and protruding ears, and the palate was tall 
and narrow. Musculoskeletal findings included long upper limbs, mild pectus excavatum, reduced 
mobility of large joints, looseness of small joints of hands, and poor coordination of fine and gross 
movements (Figure 1). The IQ was estimated at 40 to 60, and he was admitted to residential facility 
for the intellectually disabled in adult life. The II-4 had normal birth weight (3.4 kg), walked at 
21 months, had speech delay, and required special education from kindergarten onward. At age 
20 years, the height was 178 cm (65th centile) span 187 cm (70th centile) and head circumference 
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Figure 1: Kindred 9377 pedigree with three affected males. II-1 at age 24 years with tall stature and asthenic 
habitus, II-4 at age 20 years with normal stature and asthenia, II-5 at age 17 years with normal stature and 
asthenia.
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58 cm (80th centile). The forehead, and mandible were prominent, 
the ears protruded, and the palate was narrow and tall. The joints 
of the hands were hyper mobile, and he walked slowly but with 
reasonable coordination. He was able to make simple conversation 
and was docile and socially withdrawn. The II-5 weighed 4.3 kg at 
birth, walked at 16 months, and had delayed and deficient speech. 
At 17 years, the height was 173 cm (40th centile) span 184 cm (60th 
centile) and head circumference 56.4 cm (60th centile). He had 
synophrys, protruding ears, pectus excavatum, and decreased range 
of movement at large joints, hyper mobile hand joints, and mild in 
coordination. His speech was less fluent than his brothers. A hemi-
zygous missense variant [NM_005629.3:c.532A>G; NP_005620.1:p. 
(Thr178Ala)] in SLC6A8, the gene responsible for creatine transporter 
defect was detected in all three patients by whole exome sequencing 
and confirmed by Sanger sequencing of cDNA. This alteration is not 
present in the Human Gene Mutation Database (HGMD) nor is it 
listed in any of the public SNP databases (Ex AC, gnom AD, db SNP, 
1000 genomes, Exome Variant Server, Clin Var). Multiple in silico 
algorithms predict it to be damaging (Mutation Taster, SIFT, Poly 
Phen2 Hum Div, PROVEAN), and the threonine residue at position 
178 is highly conserved across species (GERP RS=3.95; Si Phy (29 
Mammals =6.15). Furthermore, the SLC6A8 gene is highly intolerant 
of missense variants (Z=3.31). The elevated urinary creatine in all 
three patients (1638, 1399, and 1315 mmol creatine/mol creatinine: 
normal range 5 to 512 mmol creatine/mol creatinine) strongly 
supports the pathogenicity. The mother was heterozygous for the 
alteration, but neither sister carried the gene variant. The mother and 
two sisters had random X-inactivation in peripheral blood. Creatine 
transporter defect is one of the more common X-linked intellectual 
disability syndromes [4]. Typically, prenatal growth is normal but 
stature decreases postnatally, eventually falling below the 3rd centile 
in one third of cases. Decreased muscle mass, hypotonia, language 
impairment, and aberrant behavior are other usual manifestations, 
and they were present in the affected males in the family reported 
here. The progressive neurological, intestinal, and psychiatric 
manifestations noted in some males with creatine transporter defect 
were not observed in this family [5]. Other X-linked intellectual 
disability syndromes with general asthenia include Snyder-Robinson 
syndrome (OMIM 309583), Allan-Herndon syndrome (OMIM 
300523), CK syndrome (OMIM 300831), Christianson syndrome 
(OMIM 300243), Arts syndrome (OMIM 301835), and spastic 
paraplegia 2 (OMIM 312920). The genes for all of these X-linked 
disorders have been identified.
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